Elsewhere online
February 08, 2017

Daily News Roundup: Chan Zuckerberg Biohub Issues First Grants

$50 Million-Plus Grant Round Opens Spending on $3 Billion Disease Pledge: The Chan Zuckerberg Biohub, launched last year by Facebook CEO Mark Zuckerberg and his wife, the physician Priscilla Chan, with a goal of eradicating disease, announced five-year grants to 47 researchers investigating biological processes that could yield new medical technologies, the journal Nature writes.

India Ends Gates Foundation Funding of Vaccine Effort: The government will take over support of the program to immunize 27 million Indian infants a year against illnesses such as measles and polio, Reuters reports, part of a broader clampdown on foreign funding of nonprofits that New Delhi says gives outsiders too much influence in national affairs.

Experts Say Trump Policies Unlikely to Derail Sustainable Investing: While the new administration aims to roll back environmental regulations, fund managers and industry analysts expect investors to remain bullish on socially responsible funds that steer capital into clean energy and other environmental and social aims, reports The Wall Street Journal (subscription).

N.H. Regulator Rules for Cancer Center in Fundraising Dispute: The state’s charity-oversight agency said the Dartmouth College-affiliated Norris Cotton Cancer Center did not misuse $6.1 million in donations by classifying them as unrestricted and putting them toward the facility’s operations, reports the New Hampshire Union Leader. The center’s former head alleges in a lawsuit filed last fall that he was ousted for questioning its use of donor dollars.

ACLU Forges Silicon Valley Ties in Wake of Immigration Order: Tech-news site the Verge looks at the technology industry’s embrace of the American Civil Liberties Union as the venerable civil-rights nonprofit battles President Trump’s policies, focusing on the unusual partnership between the ACLU and start-up accelerator Y Combinator. Read a Chronicle article on the ACLU’s recent fundraising gains.